Stay updated with breaking news from Robert Califf. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.
The World Health Organization has said global shortages of these drugs is linked to rising reports of suspected counterfeits. Last week, U.S. FDA head Robert Califf said there were likely more cases of online sales of fake obesity drugs than reported.
Unregulated supplements appear to pose an increasing risk to the well-being and lives of unsuspecting consumers. Call for enhanced consumer protections.
ChromaDex CEO Rob Fried advocates for the formation of a new group "consisting of industry players endeavoring to be righteous in their practices."
FDA Chief Dr. Robert Califf warned that fake weight loss drugs are emerging in response to shortages of Ozempic and other popular GLP-1 agonists.
Rep. Brad Wenstrup sent a letter to the FDA Commissioner to investigate possible political interference on the accelerated approval of Pfizer's COVID-19 vaccine